Ovid Therapeutics (OVID) Long-Term Investments (2021 - 2025)
Historic Long-Term Investments for Ovid Therapeutics (OVID) over the last 5 years, with Q3 2025 value amounting to $20.9 million.
- Ovid Therapeutics' Long-Term Investments fell 102.72% to $20.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.9 million, marking a year-over-year decrease of 102.72%. This contributed to the annual value of $21.0 million for FY2024, which is 1899.47% up from last year.
- As of Q3 2025, Ovid Therapeutics' Long-Term Investments stood at $20.9 million, which was down 102.72% from $20.9 million recorded in Q2 2025.
- Over the past 5 years, Ovid Therapeutics' Long-Term Investments peaked at $22.0 million during Q1 2024, and registered a low of $1.6 million during Q2 2021.
- In the last 5 years, Ovid Therapeutics' Long-Term Investments had a median value of $16.3 million in 2023 and averaged $12.5 million.
- Its Long-Term Investments has fluctuated over the past 5 years, first skyrocketed by 63907.09% in 2023, then plummeted by 505.86% in 2025.
- Over the past 5 years, Ovid Therapeutics' Long-Term Investments (Quarter) stood at $1.6 million in 2021, then soared by 244.52% to $5.6 million in 2022, then surged by 213.49% to $17.6 million in 2023, then increased by 18.99% to $21.0 million in 2024, then fell by 0.31% to $20.9 million in 2025.
- Its Long-Term Investments stands at $20.9 million for Q3 2025, versus $20.9 million for Q2 2025 and $20.9 million for Q1 2025.